颈动脉支架与内膜剥脱术20项随机试验分析概览
该综述对20项比较颈动脉内膜剥脱术(CEA)与颈动脉支架置入术(CAS)的随机对照试验(RCT)进行系统评价和荟萃分析。结果显示,CAS术后30天死亡/卒中率显著高于CEA,但30天后同侧卒中发生率两者几乎相同,CAS具有持久性。减少CAS围手术期风险可能通过更好的病例选择实现。
要点
- CAS术后30天死亡/卒中率显著高于CEA,无症状和有症状患者均如此。
- 排除围手术期风险后,CEA和CAS的9年晚期同侧卒中率均约4%,CAS持久有效。
- CAS后新发白质病变更常见(52% vs 17%),但与晚期认知障碍无关。
核心结论
- CAS术后30天死亡/卒中率高于CEA,但30天后同侧卒中发生率两者几乎相同。
- 需解决的关键问题包括新型支架技术和脑保护装置能否使CAS在症状发作14天内安全进行、CAS最佳手术量、风险因素控制和最佳药物治疗以及CEA/CAS在预防/逆转认知障碍中的作用。
研究设计与样本
- 系统评价和荟萃分析,纳入20项RCT(126篇出版物),比较CEA与CAS。
主要发现
- 7项RCT涉及3467例无症状患者,CAS术后30天死亡/卒中率显著高于CEA(OR 1.64,95%CI 1.02-2.64)。
- 10项RCT涉及5797例有症状患者,CAS术后30天死亡/卒中率显著高于CEA(OR 1.71,95%CI 1.38-2.11)。
- 排除围手术期风险后,CEA和CAS的9年晚期同侧卒中率均约4%。
- CAS后新发白质病变更常见(52% vs 17%),并与晚期卒中/短暂性脑缺血发作率更高相关(23% vs 9%),但无证据表明新发白质病变易导致晚期认知障碍。
- CAS后再狭窄更常见(10%),但未增加晚期同侧卒中;CEA后再狭窄(70%-99%)与晚期同侧卒中少量但显著增加相关(OR 3.87,95%CI 1.96-7.67;p < .001)。
关键数值与推荐
- 在以下情况选择CEA:有症状患者年龄>70岁;症状发作14天内进行干预;预测CAS后卒中风险较高的情况(节段性/远程斑块、斑块长度>13 mm、白质病变负荷重、可能需要两个或更多支架)。
临床怎么用
- 对于有症状患者年龄>70岁、症状发作14天内或预测CAS后卒中风险较高的情况,优先选择CEA。
- CAS后新发白质病变常见,但无需过度担心晚期认知障碍。
- CAS后再狭窄常见但不增加晚期同侧卒中,CEA后再狭窄(70%-99%)需关注晚期同侧卒中风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this review was to carry out primary and secondary analyses of 20 randomised controlled trials (RCTs) comparing carotid endarterectomy (CEA) with carotid artery stenting (CAS). METHODS: A systematic review and meta-analysis of data from 20 RCTs (126 publications) was carried out. RESULTS: Compared with CEA, the 30 day death/stroke rate was significantly higher after CAS in seven RCTs involving 3467 asymptomatic patients (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.02-2.64) and in 10 RCTs involving 5797 symptomatic patients (OR 1.71, 95% CI 1.38-2.11). Excluding procedural risks, late ipsilateral stroke was about 4% at 9 years for both CEA and CAS, i.e., CAS was durable. Reducing procedural death/stroke after CAS may be achieved through better case selection, e.g., performing CEA in (i) symptomatic patients aged > 70 years; (ii) interventions within 14 days of symptom onset; and (iii) situations where stroke risk after CAS is predicted to be higher (segmental/remote plaques, plaque length > 13 mm, heavy burden of white matter lesions [WMLs], where two or more stents might be needed). New WMLs were significantly more common after CAS (52% vs. 17%) and were associated with higher rates of late stroke/transient ischaemic attack (23% vs. 9%), but there was no evidence that new WMLs predisposed towards late cognitive impairment. Restenoses were more common after CAS (10%) but did not increase late ipsilateral stroke. Restenoses (70%-99%) after CEA were associated with a small but significant increase in late ipsilateral stroke (OR 3.87, 95% CI 1.96-7.67; p < .001). CONCLUSIONS: CAS confers higher rates of 30 day death/stroke than CEA. After 30 days, ipsilateral stroke is virtually identical for CEA and CAS. Key issues to be resolved include the following: (i) Will newer stent technologies and improved cerebral protection allow CAS to be performed < 14 days after symptom onset with risks similar to CEA? (ii) What is the optimal volume of CAS procedures to maintain competency? (iii) How to deliver better risk factor control and best medical treatment? (iv) Is there a role for CEA/CAS in preventing/reversing cognitive impairment?
引用
- Batchelder AJ, Saratzis A, Ross Naylor A, et al. Editor's Choice - Overview of Primary and Secondary Analyses From 20 Randomised Controlled Trials Comparing Carotid Artery Stenting With Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2019. PMID: 31492510. doi:10.1016/j.ejvs.2019.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。